Short-latency somato sensory evoked potentials (SEPs) were recorded in 45 freshly diagnosed cases of epilepsy before starting treatment. Follow-up recordings were made 6 weeks and 3 months after diphenylhydantoin, carbamazipine and phenobarbitone monotherapy were started. Serum drug levels were monitored. Both amplitude and latency of the initial component (N20) remained unchanged and were identical to a group of 30 age- and sex-matched normal individuals in whom SEPs were recorded during the period of study.
No takes yet. Share an insight, caveat, or question.
Borah et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: